Multi-Epitope Protein as a Tool of Serological Diagnostic Development for HTLV-1 and HTLV-2 Infections.


Journal

Frontiers in public health
ISSN: 2296-2565
Titre abrégé: Front Public Health
Pays: Switzerland
ID NLM: 101616579

Informations de publication

Date de publication:
2022
Historique:
received: 26 02 2022
accepted: 11 04 2022
entrez: 9 6 2022
pubmed: 10 6 2022
medline: 11 6 2022
Statut: epublish

Résumé

A multi-epitope protein expressed in a prokaryotic system, including epitopes of Env, Gag, and Tax proteins of both HTLV-1 and HTLV-2 was characterized for HTLV-1/2 serological screening. This tool can contribute to support the implementation of public policies to reduce HTLV-1/2 transmission in Brazil, the country with the highest absolute numbers of HTLV-1/2 infected individuals. The chimeric protein was tested in EIA using serum/plasma of HTLV-infected individuals and non-infected ones from four Brazilian states, including the North and Northeast regions (that present high prevalence of HTLV-1/2) and Southeast region (that presents intermediate prevalence rates) depicting different epidemiological context of HTLV-1/2 infection in our country. We enrolled samples from Pará (

Identifiants

pubmed: 35677763
doi: 10.3389/fpubh.2022.884701
pmc: PMC9168532
doi:

Substances chimiques

Epitopes 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

884701

Informations de copyright

Copyright © 2022 Franco, Rocha, Cox, Daian e Silva, da Silveira e Santos, Martins, Romanelli, Ishak, Vallinoto, Bomfim, Caterino-de-Araujo, Coelho-dos-Reis, da Fonseca and Barbosa-Stancioli.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

J Virol Methods. 2010 Jun;166(1-2):65-71
pubmed: 20219542
Blood. 1992 May 15;79(10):2789-96
pubmed: 1375112
J Virol Methods. 2009 Aug;159(2):288-90
pubmed: 19490981
J Clin Virol. 2011 Jan;50(1):13-8
pubmed: 20951636
Biochem Biophys Res Commun. 2001 Nov 23;289(1):7-12
pubmed: 11708768
Virology. 1992 Jan;186(1):274-9
pubmed: 1727602
AIDS Res Hum Retroviruses. 2015 May;31(5):543-9
pubmed: 25464979
Infect Genet Evol. 2021 Dec;96:105141
pubmed: 34781039
AIDS Res Hum Retroviruses. 2017 Apr;33(4):382-385
pubmed: 27750018
J Clin Microbiol. 2017 Jul;55(7):2180-2187
pubmed: 28468860
Rev Soc Bras Med Trop. 2021 Mar 08;54:
pubmed: 33681940
mSphere. 2020 Sep 30;5(5):
pubmed: 32999083
J Clin Microbiol. 2018 Nov 27;56(12):
pubmed: 30232131
Trans R Soc Trop Med Hyg. 2009 Apr;103(4):420-2
pubmed: 19155035
Braz J Microbiol. 2020 Jun;51(2):637-645
pubmed: 31993990
Rev Panam Salud Publica. 2010 May;27(5):330-7
pubmed: 20602066
Rev Soc Bras Med Trop. 2019 Oct 10;52:e20190343
pubmed: 31618310
BMC Infect Dis. 2019 May 22;19(1):459
pubmed: 31117977
Virology. 1993 Mar;193(1):80-8
pubmed: 7679862
J Virol Methods. 2011 May;173(2):280-6
pubmed: 21349293
J Gen Intern Med. 2002 Aug;17(8):646-9
pubmed: 12213147
Cad Saude Publica. 2005 May-Jun;21(3):926-31
pubmed: 15868051
Transfusion. 2011 Apr;51(4):692-701
pubmed: 20946198
J Clin Virol. 2008 Jun;42(2):149-55
pubmed: 18346935
AIDS Res Hum Retroviruses. 2012 Oct;28(10):1265-72
pubmed: 22324906
Cad Saude Publica. 2003 Jul-Aug;19(4):901-14
pubmed: 12973556
PLoS Negl Trop Dis. 2021 Nov 1;15(11):e0009925
pubmed: 34724004
PLoS Negl Trop Dis. 2018 Nov 12;12(11):e0006913
pubmed: 30418973
Viruses. 2011 Aug;3(8):1320-31
pubmed: 21994781
J Med Virol. 2010 Oct;82(10):1746-53
pubmed: 20827773
Rev Inst Med Trop Sao Paulo. 2015 Jan-Feb;57(1):1-13
pubmed: 25651320
J Infect Dis. 1992 Feb;165(2):268-72
pubmed: 1370526
Sci Rep. 2019 Oct 14;9(1):14750
pubmed: 31611600
J Virol. 1989 Nov;63(11):4952-7
pubmed: 2677406
J Clin Microbiol. 1992 Feb;30(2):296-9
pubmed: 1347047
Rev Soc Bras Med Trop. 2020 Feb 07;53:e20190378
pubmed: 32049201
Braz J Infect Dis. 2017 May - Jun;21(3):297-305
pubmed: 28343818
Biometrics. 1977 Mar;33(1):159-74
pubmed: 843571
Rev Soc Bras Med Trop. 2021 Jun 02;54:e01752021
pubmed: 34105630
J Immunol. 2002 Jun 1;168(11):5499-506
pubmed: 12023344
J Med Virol. 2010 Sep;82(9):1606-11
pubmed: 20648617
Rev Inst Med Trop Sao Paulo. 2007 Jul-Aug;49(4):225-30
pubmed: 17823751
Mem Inst Oswaldo Cruz. 2018 Feb;113(2):130-134
pubmed: 29236927
Lancet Microbe. 2022 Mar;3(3):e164
pubmed: 35544072
Rev Inst Med Trop Sao Paulo. 2007 Nov-Dec;49(6):361-4
pubmed: 18157402

Auteurs

Gabriela de Melo Franco (GM)

Laboratório de Virologia Básica e Aplicada, Departamento de Microbiologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, Brazil.
GIPH-Indisciplinary HTLV Research Group, Belo Horizonte, Brazil.

Anderson Santos da Rocha (AS)

Laboratório de Virologia Básica e Aplicada, Departamento de Microbiologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, Brazil.
GIPH-Indisciplinary HTLV Research Group, Belo Horizonte, Brazil.

Laura Jorge Cox (LJ)

Laboratório de Virologia Básica e Aplicada, Departamento de Microbiologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, Brazil.
GIPH-Indisciplinary HTLV Research Group, Belo Horizonte, Brazil.

Danielle Soares de Oliveira Daian E Silva (DSO)

Laboratório de Virologia Básica e Aplicada, Departamento de Microbiologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, Brazil.
GIPH-Indisciplinary HTLV Research Group, Belo Horizonte, Brazil.

Débora Marques da Silveira E Santos (DM)

Laboratório de Virologia Básica e Aplicada, Departamento de Microbiologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, Brazil.
GIPH-Indisciplinary HTLV Research Group, Belo Horizonte, Brazil.

Marina Lobato Martins (ML)

GIPH-Indisciplinary HTLV Research Group, Belo Horizonte, Brazil.
Serviço de Pesquisa, Fundação HEMOMINAS, Belo Horizonte, Brazil.

Luis Claudio Romanelli (LC)

GIPH-Indisciplinary HTLV Research Group, Belo Horizonte, Brazil.
Serviço de Pesquisa, Fundação HEMOMINAS, Belo Horizonte, Brazil.

Ricardo Ishak (R)

Laboratório de Virologia, Instituto de Ciências Biológicas, Universidade Federal do Pará (UFPA), Belém, Brazil.

Antonio C R Vallinoto (ACR)

Laboratório de Virologia, Instituto de Ciências Biológicas, Universidade Federal do Pará (UFPA), Belém, Brazil.

Maria Rosa Q Bomfim (MRQ)

Universidade CEUMA, São Luis, Brazil.

Adele Caterino-de-Araujo (A)

Centro de Imunologia, Instituto Adolfo Lutz, São Paulo, Brazil.

Jordana G A Coelho-Dos-Reis (JGA)

Laboratório de Virologia Básica e Aplicada, Departamento de Microbiologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, Brazil.
GIPH-Indisciplinary HTLV Research Group, Belo Horizonte, Brazil.

Flávio Guimarães da Fonseca (FG)

Laboratório de Virologia Básica e Aplicada, Departamento de Microbiologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, Brazil.

Edel Figueiredo Barbosa-Stancioli (EF)

Laboratório de Virologia Básica e Aplicada, Departamento de Microbiologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, Brazil.
GIPH-Indisciplinary HTLV Research Group, Belo Horizonte, Brazil.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH